SCHEMBL3593676

SCHEMBL3593676

CCc1cc(C(=O)c2ccc(OC(F)(F)F)cc2)c(NC(=O)CN[C@@H](CC)C(=O)O)s1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 4/20 0.54
GFER P55789 1/20 0.53
MAPT P10636 8/20 0.49
ALDH1A1 P00352 8/20 0.49
KDM4E B2RXH2 7/20 0.49
GAA P10253 2/20 0.49
TDP1 Q9NUW8 1/20 0.49
L3MBTL1 Q9Y468 2/20 0.48
LMNA P02545 1/20 0.48
POLB P06746 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.43
RAB9A P51151 2/20 0.43
KMT2A Q03164 2/20 0.43
MEN1 O00255 1/20 0.43
GRIN2C Q14957 1/20 0.42
HSD17B10 Q99714 2/20 0.41
HPGD P15428 2/20 0.41
TSHR P16473 1/20 0.41
CYP2C9 P11712 2/20 0.40
CYP1A2 P05177 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3593140 1.00 NPSR1 (0.54) NPSR1GFERMAPTALDH1A1KDM4E
SCHEMBL3599298 0.92 NPSR1 (0.52) NPSR1GFERMAPTALDH1A1KDM4E
SCHEMBL3587607 0.90 GFER (0.56) NPSR1GFERMAPTALDH1A1KDM4E
SCHEMBL3587618 0.90 GFER (0.56) NPSR1GFERMAPTALDH1A1KDM4E
SCHEMBL3591935 0.90 GFER (0.56) NPSR1GFERMAPTALDH1A1KDM4E
SCHEMBL3588177 0.88 NPSR1 (0.53) NPSR1GFERMAPTALDH1A1KDM4E
SCHEMBL3588171 0.88 NPSR1 (0.53) NPSR1GFERMAPTALDH1A1KDM4E
SCHEMBL3596328 0.88 NPSR1 (0.53) NPSR1GFERMAPTALDH1A1KDM4E
SCHEMBL3583016 0.87 NPSR1 (0.52) NPSR1GFERMAPTALDH1A1KDM4E
SCHEMBL3588145 0.85 NPSR1 (0.63) NPSR1GFERMAPTALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100063065-A1 THIOPHENE DERIVATIVES AS PPAR AGONISTS I INPHARMATICA LIMITED (GB) 2010-03-11 US claimed
US-20100063065-A1 THIOPHENE DERIVATIVES AS PPAR AGONISTS I INPHARMATICA LIMITED (GB) 2010-03-11 US disclosed
US-20100063065-A1 THIOPHENE DERIVATIVES AS PPAR AGONISTS I INPHARMATICA LIMITED (GB) 2010-03-11 US disclosed
US-20100063065-A1 THIOPHENE DERIVATIVES AS PPAR AGONISTS I INPHARMATICA LIMITED (GB) 2010-03-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100063065-A1 THIOPHENE DERIVATIVES AS PPAR AGONISTS I PPARG, PPARD, PPARA NPSR1 706/4885GFER 996/4885MAPT 4061/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.